1. Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation: The ALTTO and Neo-ALTTO Trials (Principal Investigators, Martine Piccart-Gebhart and Edith A. Perez)

   • Antonio C. Wolff

   Clinical Trial Report 18 December 2010 Pages: 1 - 3

2. Endocrine Therapy Plus Zoledronic Acid in Premenopausal Breast Cancer: Review of a Clinical Trial

   • Catherine M. Kelly
   • Eleni Andreopoulou

   Clinical Trial Report 28 January 2011 Pages: 4 - 5

3. Insulin-Like Growth Factor Pathway–Targeted Therapy in Breast Cancer

   • Saad J. Sirop
   • Paul Haluska

   ReviewPaper 14 December 2010 Pages: 6 - 14

   

4. Hedgehog Pathway Inhibitors: Potential Applications in Breast Cancer

   • Yee Hong Chia
   • Cynthia X. Ma

   ReviewPaper 03 December 2010 Pages: 15 - 23

   

5. Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents

   • Catherine Oakman
   • Libero Santarpia
   • Angelo Di Leo

   ReviewPaper 13 January 2011 Pages: 24 - 33

   

6. Epigenetic Therapy in Breast Cancer

   • Maryam B. Lustberg
   • Bhuvaneswari Ramaswamy

   ReviewPaper 22 December 2010 Pages: 34 - 43

   

7. PARP Inhibitors

   • Hongyan Liang
   • Antoinette R. Tan

   ReviewPaper 22 January 2011 Pages: 44 - 54

   

8. Targeted Therapies for HER2 Breast Cancer: A View of the Landscape

   • Vishal Rana
   • Ramona F. Swaby

   ReviewPaper 30 January 2011 Pages: 55 - 62

9. The PI3K/AKT/mTOR Signaling Pathway: Implications in the Treatment of Breast Cancer

   • Eleni Andreopoulou

   ReviewPaper 30 January 2011 Pages: 63 - 74